As a gold standard for clinical decision-making, the recent update of these guidelines recognizes the valuable role of ERG in both diagnosing and managing DR.
The integration of routine electroretinography (ERG) in clinical practice enhances patient management by providing objective, actionable data for diagnosing.
Investing in technology can significantly enhance patient care while boosting profitability for optometry practices. This article highlights three key technological additions that were made to achieve these outcomes.
In this podcast, Dr. Bryan Holman discusses his clear process and strategy when introducing new technology into his practice and how he successfully integrated the RETeval, his most recent technology.
This article discusses where to turn when you are providing treatment in the form of lenses and vision therapy and are not seeing the improvement that you expect.
Discover the latest in visual electrophysiology with two ERG courses at EURETINA 2024. Profs. P. Stanga, D. Pojda-Wilczek, and four other experts will guide you through integrating ERG into your practice.
This article explores a diverse selection of newer optometric devices, as well as those used in specialized areas of care, designed to help you enhance your skills and advance in specific fields of optometry.
The RETeval has been referenced in over 200 publications, demonstrating its increasing importance in diagnosing and managing retina and optic nerve diseases.
Dr. Melissa Richard writes about 3 clear winners in her quest to enhance care and spur financial growth, one of them being the RETeval handheld ERG, which she uses to manage her diabetic and low vision patients.
Daniel Kiernan, MD, FACS, retina specialist, describes that even though advancements in imaging and functional testing have significantly improved the diagnosis and management of DR, the current staging system falls short.
Dr. Dorothy Hitchmoth explains how the positive impact on public health and the financial rewards make diabetes care a cornerstone for the success and sustainability of optometrists who are willing to embrace this transformative approach.
Read this article to see why Dr. Bobby "Chip" Wood says he thinks the RETeval handheld ERG will change functional testing in 2024 much like OCT revolutionized structural imaging in years past.
With prevalence of diabetes on the rise, recognizing the early signs of diabetic retinopathy is critical for intervention. In this article, Dr. Anna Bedwell discusses devices that can aid in detection and management of the disease.
Dr. Malique Payne recently acquired the RETeval, a portable electroretinogram that she takes with her from location to location. She explains how the device tests retinal function without subjectivity.
